JESSICA OLIVER: Open Payments
NPI 1114585940 · THOMASVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176,011 in 423 payments from 12 companies in 2025. Trend: 2023 $13,759 · 2024 $40,546 · 2025 $176,011
Speaker / faculty: $93,828Honoraria: $55,176Travel & lodging: $13,284Food & beverage: $7,348Consulting: $6,375
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 147 | $67,894 |
| Axsome Therapeutics, Inc. | 136 | $63,441 |
| Neurocrine BioSciences, Inc. | 72 | $43,109 |
| E.R. Squibb & Sons, L.L.C. | 17 | $478 |
| Vanda Pharmaceuticals Inc. | 9 | $298 |
| Teva Pharmaceuticals USA, Inc. | 16 | $289 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $282 |
| Alkermes, Inc. | 6 | $108 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
Products named: VRAYLAR, Auvelity, INGREZZA, COBENFY, FANAPT, CAPLYTA, AUSTEDO XR, LYBALVI.
Industry payments across GA — which companies pay providers there.
